Showing results (41-50 of 60) with videos related to
Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
Node-negative breast cancer treated by modified radical mastectomy without adjuvant therapies: variables associated with disease recurrence and survivorshipR A Huseby, H E Ownby, J Frederick, et al.Transfusion|May 22, 1998
Retention of "safe" blood donors. The Retrovirus Epidemiology Donor StudyR A Thomson, J Bethel, A Y Lo, et al.Breast Cancer Research and Treatment|January 1, 1983
Interrupted pregnancy as an indicator of poor prognosis in T1, 2, N0, M0 primary breast cancerH E Ownby, S Martino, L D Roi, et al.Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|November 11, 1999
Patients' perception of recovery after third molar surgeryS M Conrad, G H Blakey, D A Shugars, et al.Breast Cancer Research and Treatment|January 1, 1982
Prognostic significance of serum IgE levels in primary breast cancerD R Ownby, H E Ownby, L D Roi, et al.JAMA|October 3, 1998
False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. Retrovirus Epidemiology Donor StudyS Kleinman, M P Busch, L Hall, et al.American Journal of Clinical Pathology|August 1, 1987
Predictors of recurrence and survival of patients with breast cancerJ Russo, J Frederick, H E Ownby, et al.Journal of the National Cancer Institute|July 1, 1985
Racial differences in breast cancer patientsH E Ownby, J Frederick, J Russo, et al.Transfusion|February 1, 1997
Loss of volunteer blood donors because of unconfirmed enzyme immunoassay screening results. Retrovirus Epidemiology Donor StudyH E Ownby, J J Korelitz, M P Busch, et al.Transfusion|October 1, 1994
Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor StudyJ J Korelitz, A E Williams, M P Busch, et al.Pageof 6